| Value | ₹11.85 Cr |
|---|
BSE filing, NSE: JTAPARIA. Summary written from the filing by ALFA Finder's alert engine.
Annvrridhhi Ventures Ltd: key numbers
- Share price
- ₹10.06
- Market cap
- ₹28.25 Cr
- Revenue (annual)
- ₹99.87 Cr
- Net profit (annual)
- ₹0.72 Cr
- P/E (TTM)
- 34.2×Sector 45.0×
- Promoter holding
- 51.77%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Annvrridhhi Ventures Ltd
All →Annvrridhhi Ventures Other Announcement
Annvrridhhi Ventures Limited filed the Regulation 74(5) compliance certificate from its Registrar and Transfer Agent, Purva Sharegistry (India) Private Limited, for the quarter ended September 2026.
Annvrridhhi Ventures Management Change
Annvrridhhi Ventures Limited received shareholder approval to appoint Ms. Mini Kumar as a Non-Executive Independent Director, regularizing her previous additional director role.
Annvrridhhi Ventures Annual General Meeting
Annvrridhhi Ventures issued an addendum to its Annual General Meeting notice. The addendum seeks shareholder approval for material related party transaction limits for the upcoming year.
Annvrridhhi Ventures Price Movement Clarification
Annvrridhhi Ventures stated that recent stock price fluctuations are market-driven. The company confirmed full compliance with all necessary SEBI disclosure regulations.
Annvrridhhi Ventures Annual Report
Annvrridhhi Ventures Ltd has submitted its Annual Report for the financial year 2025-26, including the notice for the 46th Annual General Meeting on September 30, 2026.
Annvrridhhi Ventures Management Change
Annvrridhhi Ventures Ltd has appointed Ms. Mini Kumar as an Additional Non-Executive Independent Director, effective September 5, 2026.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr